Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
hepatocellular-carcinomaimmune-checkpoint-inhibitorradiotherapy
hepatocellular carcinoma (hcc), radiotherapy, adjuvant, immune checkpoint inhibitor, tace, narrow margin, hepatocellular carcinoma, radiotherapy, sintilimab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 896675
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.